Skip to main content
V

VIVI

VIVI designs insulated, battery‑free cases that keep temperature‑sensitive medications such as insulin pens, GLP‑1 pens, EpiPens and medication vials safe in extreme hot or cold conditions. Their patented VIVI Cap Smart adds digital tracking to maintain consistent dosing, while all products are TSA‑compliant, pocket‑sized, and require no charging or maintenance, providing hassle‑free protection for daily use.

Sammamish, United StatesFounded 201420500+ followers
Updated 1 month ago

Funding

$1.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Insulin, GLP‑1 pens, EpiPens and other temperature‑sensitive injectable medications lose potency when exposed to extreme heat, cold, or light, leading to ineffective dosing and potential health risks. Maintaining proper storage conditions while traveling or during daily activities is difficult without bulky, powered refrigeration devices.

Solution

VIVI offers a line of patented, battery‑free insulated cases that protect insulin pens, GLP‑1 pens, EpiPens, and other temperature‑sensitive medication devices from extreme temperatures and light. The passive thermal insulation uses a heat‑absorbing material originally developed for aerospace, providing continuous 24/7/365 protection without the need for charging, ice packs, or refrigeration. Select models (VIVI Cap Smart) add Bluetooth connectivity and a built‑in display that tracks time since the last injection and syncs with a mobile app for dose logging, reminders, and data export. All cases are TSA‑compliant, pocket‑sized, and designed for long‑term reuse, delivering reliable medication stability for users on the go.

Target Audience

People who use insulin, GLP‑1 analogues, or epinephrine auto‑injectors—including individuals with diabetes, caregivers, and allergy patients—who need reliable temperature control during daily life, travel, or outdoor activities.

Features

  • Passive, patented insulation that maintains medication below 86 °F (30 °C) in hot environments and releases stored heat when ambient temperature drops, requiring no batteries or external power
  • Compact, pocket‑friendly form factor that fits standard insulin and GLP‑1 pen caps, as well as EpiPen® devices
  • TSA‑approved design eliminates the need for ice packs or refrigeration during air travel
  • VIVI Cap Smart includes Bluetooth 4.0, a low‑power display showing time since last injection, connectivity status, and battery level
  • Mobile app (iOS 10+/Android 6+) logs injections, glucose readings, meals, pen age, and remaining volume; supports multiple pens and generates PDF reports for clinicians
  • FDA and CE registered, with performance validated in peer‑reviewed studies
  • Durable construction lasts for years without maintenance or replacement of consumable components
This profile is AI-generated and may contain inaccuracies.